Titre : Péricytes

Péricytes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neoplasm Recurrence, Local
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Péricytes : Questions médicales les plus fréquentes", "headline": "Péricytes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Péricytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-20", "dateModified": "2025-03-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Péricytes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mésoderme", "url": "https://questionsmedicales.fr/mesh/D008648", "about": { "@type": "MedicalCondition", "name": "Mésoderme", "code": { "@type": "MedicalCode", "code": "D008648", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A16.504.660" } } }, "about": { "@type": "MedicalCondition", "name": "Péricytes", "alternateName": "Pericytes", "code": { "@type": "MedicalCode", "code": "D020286", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alexander Birbrair", "url": "https://questionsmedicales.fr/author/Alexander%20Birbrair", "affiliation": { "@type": "Organization", "name": "Departamento de Patologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil. birbrair@icb.ufmg.br." } }, { "@type": "Person", "name": "John C Chappell", "url": "https://questionsmedicales.fr/author/John%20C%20Chappell", "affiliation": { "@type": "Organization", "name": "Center for Heart and Reparative Medicine Research, Fralin Biomedical Research Institute at Virginia Tech-Carilion, Roanoke, VA 24016, USA." } }, { "@type": "Person", "name": "Nusrat S Khan", "url": "https://questionsmedicales.fr/author/Nusrat%20S%20Khan", "affiliation": { "@type": "Organization", "name": "BHF Centre for Cardiovascular Science, Queen's Medical Research Center, University of Edinburgh, Edinburgh, UK." } }, { "@type": "Person", "name": "Chi F Hung", "url": "https://questionsmedicales.fr/author/Chi%20F%20Hung", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, USA." } }, { "@type": "Person", "name": "Carole L Wilson", "url": "https://questionsmedicales.fr/author/Carole%20L%20Wilson", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer.", "datePublished": "2024-08-20", "url": "https://questionsmedicales.fr/article/39164626", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12799-1" } }, { "@type": "ScholarlyArticle", "name": "Examination of the effectiveness of local therapy for oligo-recurrence of EGFR-mutated NSCLC.", "datePublished": "2023-01-31", "url": "https://questionsmedicales.fr/article/36720507", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1759-7714.14805" } }, { "@type": "ScholarlyArticle", "name": "Development of a consensus-based delineation guideline for locally recurrent rectal cancer.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36410547", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.radonc.2022.11.008" } }, { "@type": "ScholarlyArticle", "name": "The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary.", "datePublished": "2022-08-08", "url": "https://questionsmedicales.fr/article/35939185", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-022-06680-7" } }, { "@type": "ScholarlyArticle", "name": "Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.", "datePublished": "2022-05-29", "url": "https://questionsmedicales.fr/article/35643422", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-022-09650-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Structures de l'embryon", "item": "https://questionsmedicales.fr/mesh/D004628" }, { "@type": "ListItem", "position": 3, "name": "Feuillets embryonnaires", "item": "https://questionsmedicales.fr/mesh/D005855" }, { "@type": "ListItem", "position": 4, "name": "Mésoderme", "item": "https://questionsmedicales.fr/mesh/D008648" }, { "@type": "ListItem", "position": 5, "name": "Péricytes", "item": "https://questionsmedicales.fr/mesh/D020286" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Péricytes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Péricytes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Péricytes", "description": "Comment diagnostiquer une dysfonction des péricytes ?\nQuels tests sont utilisés pour évaluer les péricytes ?\nLes péricytes peuvent-ils être visualisés par IRM ?\nY a-t-il des marqueurs spécifiques pour les péricytes ?\nLes tests génétiques sont-ils utiles pour les péricytes ?", "url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Péricytes", "description": "Quels symptômes indiquent une dysfonction des péricytes ?\nLes péricytes affectent-ils la vision ?\nPeut-on observer des symptômes neurologiques liés aux péricytes ?\nLes péricytes sont-ils liés à des douleurs chroniques ?\nLes péricytes peuvent-ils causer des troubles cardiaques ?", "url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Péricytes", "description": "Comment prévenir les dysfonctionnements des péricytes ?\nLe contrôle de la pression artérielle aide-t-il les péricytes ?\nLes habitudes alimentaires influencent-elles les péricytes ?\nL'exercice physique est-il bénéfique pour les péricytes ?\nLe tabagisme affecte-t-il les péricytes ?", "url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Péricytes", "description": "Quels traitements existent pour les dysfonctionnements des péricytes ?\nLes thérapies géniques peuvent-elles aider les péricytes ?\nLes médicaments vasodilatateurs sont-ils efficaces ?\nY a-t-il des traitements naturels pour les péricytes ?\nLa rééducation peut-elle aider les patients avec des problèmes de péricytes ?", "url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Péricytes", "description": "Quelles complications peuvent survenir avec des péricytes dysfonctionnels ?\nLes péricytes sont-ils liés à des maladies neurodégénératives ?\nLes complications cardiaques sont-elles possibles ?\nLes péricytes affectent-ils la cicatrisation des plaies ?\nLes complications rénales sont-elles possibles avec des péricytes altérés ?", "url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Péricytes", "description": "Quels sont les facteurs de risque pour les dysfonctionnements des péricytes ?\nL'âge est-il un facteur de risque pour les péricytes ?\nLe stress influence-t-il les péricytes ?\nLes maladies métaboliques augmentent-elles les risques ?\nL'obésité est-elle un facteur de risque pour les péricytes ?", "url": "https://questionsmedicales.fr/mesh/D020286?mesh_terms=Neoplasm+Recurrence,+Local&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des péricytes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des biopsies tissulaires et des techniques d'imagerie avancées." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les péricytes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests histologiques et des analyses immunohistochimiques sont couramment utilisés." } }, { "@type": "Question", "name": "Les péricytes peuvent-ils être visualisés par IRM ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM peut aider à visualiser les changements vasculaires associés aux péricytes." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour les péricytes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme NG2 et PDGFR-β sont utilisés pour identifier les péricytes." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les péricytes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent aider à identifier des mutations affectant les péricytes." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction des péricytes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'œdème, la douleur et des troubles circulatoires peuvent apparaître." } }, { "@type": "Question", "name": "Les péricytes affectent-ils la vision ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysfonction peut entraîner des problèmes de circulation dans la rétine." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques liés aux péricytes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles vasculaires cérébraux peuvent causer des symptômes neurologiques." } }, { "@type": "Question", "name": "Les péricytes sont-ils liés à des douleurs chroniques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une dysfonction des péricytes peut contribuer à des douleurs chroniques par une mauvaise circulation." } }, { "@type": "Question", "name": "Les péricytes peuvent-ils causer des troubles cardiaques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies des péricytes peuvent affecter la circulation et contribuer à des troubles cardiaques." } }, { "@type": "Question", "name": "Comment prévenir les dysfonctionnements des péricytes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain, avec une alimentation équilibrée et de l'exercice régulier." } }, { "@type": "Question", "name": "Le contrôle de la pression artérielle aide-t-il les péricytes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle de la pression artérielle préserve la santé des péricytes." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les péricytes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants et en oméga-3 peut soutenir la santé des péricytes." } }, { "@type": "Question", "name": "L'exercice physique est-il bénéfique pour les péricytes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la circulation sanguine et la fonction des péricytes." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il les péricytes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme nuit à la santé vasculaire et peut altérer la fonction des péricytes." } }, { "@type": "Question", "name": "Quels traitements existent pour les dysfonctionnements des péricytes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies médicamenteuses et des interventions chirurgicales." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles aider les péricytes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique est explorée pour corriger les anomalies des péricytes." } }, { "@type": "Question", "name": "Les médicaments vasodilatateurs sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les vasodilatateurs peuvent améliorer la circulation en agissant sur les péricytes." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour les péricytes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches naturelles, comme les antioxydants, peuvent soutenir la santé vasculaire." } }, { "@type": "Question", "name": "La rééducation peut-elle aider les patients avec des problèmes de péricytes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la rééducation peut améliorer la circulation et la fonction vasculaire." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des péricytes dysfonctionnels ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles circulatoires, des œdèmes et des maladies vasculaires." } }, { "@type": "Question", "name": "Les péricytes sont-ils liés à des maladies neurodégénératives ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysfonction des péricytes peut contribuer à des maladies comme Alzheimer." } }, { "@type": "Question", "name": "Les complications cardiaques sont-elles possibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes de péricytes peuvent entraîner des maladies cardiaques ischémiques." } }, { "@type": "Question", "name": "Les péricytes affectent-ils la cicatrisation des plaies ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une dysfonction des péricytes peut retarder la cicatrisation en affectant la vascularisation." } }, { "@type": "Question", "name": "Les complications rénales sont-elles possibles avec des péricytes altérés ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des péricytes dysfonctionnels peuvent contribuer à des maladies rénales chroniques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les dysfonctionnements des péricytes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète et le tabagisme." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les péricytes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des péricytes et la santé vasculaire." } }, { "@type": "Question", "name": "Le stress influence-t-il les péricytes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut nuire à la santé vasculaire et affecter les péricytes." } }, { "@type": "Question", "name": "Les maladies métaboliques augmentent-elles les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète augmentent le risque de dysfonction des péricytes." } }, { "@type": "Question", "name": "L'obésité est-elle un facteur de risque pour les péricytes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est associée à des troubles vasculaires et à une dysfonction des péricytes." } } ] } ] }

Sources (10000 au total)

Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer.

Local recurrence is common after curative resections of rectal cancer. Surgical resection is considered a primary curative treatment option for patients with locally recurrent rectal cancer (LRRC). LR... From April 2010 to March 2022, a total of 166 patients underwent surgery for LRRC in the pelvic region at our institutions. Clinicopathological background and VTE incidence were compared retrospective... Among the 166 patients included in the study, 55 patients (33.1%) needed sacral resection. Pharmacological prophylaxis for prevention of VTE was performed in 121 patients (73.3%), and the incidence of... This study demonstrates that surgery for LRRC combined with sacral resection could be a significant risk factor for VTE....

Examination of the effectiveness of local therapy for oligo-recurrence of EGFR-mutated NSCLC.

The effectiveness of local therapy has been reported in patients with oligo-recurrence of non-small cell lung cancer (NSCLC), a metachronous recurrence with a limited number of recurrences, which can ... From 2004 to 2014, 811 patients underwent complete resection for NSCLC at Kitasato University Hospital and, of these, 244 patients developed recurrence. Oligo-recurrence was defined as the presence of... We retrospectively examined and compared the effects of EGFR-TKIs with those of radical local therapy in patients with oligo-recurrent EGFR-mutated NSCLC. The five-year post-recurrence survival (PRS) ... Radical local therapy did not affect PRS in patients with oligo-recurrent EGFR-mutated NSCLC. Even in cases of oligo-recurrence, the administration of local therapy in patients with EGFR-mutated NSCLC...

Development of a consensus-based delineation guideline for locally recurrent rectal cancer.

Neoadjuvant chemoradiotherapy (nCRT) is used in locally recurrent rectal cancer (LRRC) to increase chances of a radical surgical resection. Delineation in LRRC is hampered by complex disease presentat... Eight radiation oncologists, from Dutch and Swedish expert centres, participated in two meetings, delineating GTV and CTV in six cases. Regions at-risk for re-recurrence or irradical resection were id... Inter-observer variation in delineation of LRRC appeared large. Multidisciplinary evaluation per case is beneficial in determining target volumes. The following consensus regarding target volumes was ... This study provides a first consensus-based delineation guideline for LRRC. Analyses of re-recurrences is needed to understand disease behaviour and to optimize delineation guidelines accordingly....

The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary.

Describes the relevance of -various classification methods for ipsilateral breast tumour recurrence (IBTR) as either true recurrence (TR) or new primary (NP) on both disease-specific survival (DSS) an... Two hundred and thirty-four of 4359 women undergoing breast-conserving therapy experienced IBTR. We compared the impact of four known classification methods and two newly created classification method... For three of the methods, a better DSS was observed for NP compared to TR with the hazard ratio (HR) ranging from 0.5 to 0.6. The new Twente method classification, comprising all classification criter... IBTR classified as TR or NP has a prognostic value for both DSS and DMFS, but depends on the classification method used. Developing and validating a generally accepted form of classification are imper...

Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.

The international consensus guidelines for intraductal papillary mucinous neoplasm of the pancreas (IPMN) presented clinical features as indications for surgery. Whereas surveillance for recurrence, i... This study aimed to assess the clinical features of recurrence at the remnant pancreas (Rem-Panc) and extra-pancreas (Ex-Panc) after surgery for IPMN. Ninety-one patients of IPMN that underwent detail... The IPMNs were finally diagnosed as low-grade dysplasia (LDA, n = 42), high-grade dysplasia (HAD, n = 19), and invasive carcinoma (IPMC, n = 30). Recurrence was observed in 26 patients (29%), of which... The risk factors for Rem-Panc and Ex-Panc recurrence differ. Therefore, optimal surveillance on these features is desirable to ensure that repeat pancreatectomy for Rem-Panc recurrence can be an appro...

Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.

Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months. The magnetic resonance spectroscopy imaging (MRSI) has been used for the detection of brain tumor... The research was performed in accordance with the preferred reporting items for systematic review and meta-analysis guidelines. International electronic databases including 15 English sources were inv... Nine studies were enrolled in the meta-analysis with a total of 354 patients (203 male and 151 female) whose average age ranged from 4 to 74 years. Anbarloui et al., Elias et al., Nemattalla et al., S... MR spectroscopy is effective in distinguishing recurrent brain tumors from necrosis. Our meta-analysis revealed that Cho/NAA, Cho/Cr, and NAA/Cr ratios were significantly better predictor of detected ...

A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.

Despite multimodal therapy 5-15% of patients who undergo resection for advanced rectal cancer (LARC) will develop local recurrence. Management of locally recurrent rectal cancer (LRRC) presents a sign... A systematic review was carried out searching MEDLINE, EMBASE and COCHRANE Trials database for all studies assessing pathological factors influencing survival following pelvic exenteration for LARC or... Nine cohort studies met inclusion criteria, reporting outcomes for 2864 patients. Meta-analysis was not possible due to significant heterogeneity of reported outcomes. Resection margin status and noda... Pathological resection margin status is widely demonstrated to influence disease free and overall survival following pelvic exenteration for rectal cancer. With increasing R0 rates, other adverse tumo...

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

A first pilot study showed that an image-guided navigation system could improve resection margin rates in locally advanced (LARC) and locally recurrent rectal cancer (LRRC) patients. Incremental surgi... A Markov decision model was constructed to estimate the expected costs and outcomes for navigated and standard surgery. The input parameters were based on pilot data from a prospective (navigation coh... Based on this early evaluation, navigated surgery showed incremental costs of €3141 and €2896 in LARC and LRRC. In LARC, navigated surgery resulted in 2.05 Quality-Adjusted Life Years (QALYs) vs 2.02 ... Adding navigation system use is expected to be cost-effective in LRRC and has the potential to become cost-effective in LARC. To increase the probability of being cost-effective, it is crucial to opti...

The role of surgery in recurrent local cerebral metastases: a multi-institutional retrospective analysis.

Local recurrent brain metastases are defined as lesions that recur in the brain at the same site after a previous local therapy. In patients already submitted to surgery, a second operation may be pot... 37 patients submitted to surgery for a local, histologically confirmed, recurrent brain metastases between 2000 and 2022 were retrospectively analyzed with respect to the following parameters: age, hi... A significant improvement of post-operative KPS status was obtained after second surgery. At multivariate analysis better results in terms of OS were achieved in patients with a pre-operative KPS ≥ 70... Surgical resection of local recurrent brain metastases may improve patients ́ neurologic conditions allowing more time for systemic therapies to act with a low incidence of surgery-related morbidity a...

Salvage radiotherapy for locally recurrent cervical and endometrial carcinoma: clinical outcomes and toxicities.

The management of locally recurrent gynecological carcinoma remains a challenge due to the limited availability of data. This study aims to share our institutional experience in using definitive radio... The study retrospectively reviewed 20 patients in our hospital completing salvage 3D image-based HDR brachytherapy, with or without EBRT, for locally recurrent cervical and endometrial carcinoma after... During a median observation period of 21 months, the study reported a tumor objective response rate of 95%. The 3-year DFS and OS rates were 89.4% and 90.9%, respectively. The EBRT combined with brach... 3D image-guided brachytherapy combined with EBRT shows effective tumor control and acceptable toxicity profile for women with locally recurrent gynecologic cancer. The success in managing vaginal recu...